Funding for this research was provided by:
National Natural Science Foundation of China (81641002)
National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2017ZX09101002-002-005)
Received: 23 February 2021
Accepted: 27 May 2021
First Online: 6 June 2021
: Experimental protocols were approved by the Laboratory Animal Ethics Committee of the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences (License Number SCXK 2016-0006).
: The authors declare that they have no competing interests.